Genomma Lab To Increase Sales By 45%

Mexican drugmaker Genomma Lab has announced that it intends to increase sales by up to 45% in 2010, chiefly through product diversification and global expansion. It has not alluded to any acquisitions as providing the drive for growth and therefore BMI believes the company to be concentrating on marketing its portfolio in new therapeutic categories.

To read the full article, please choose one of the following options: